Gene · 915
Papers3,597
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 3,597
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single-cell transcriptomics reveals peripheral immune responses in non-segmental vitiligo. | Front Immunol | 2023 | 38077333 | PubTator, text mining | PubMed |
| Assessment tool based on fatty acid metabolic signatures for predicting the prognosis and treatment response in bladder cancer. | Heliyon | 2023 | 38076064 | PubTator, text mining | PubMed |
| Epigenetic and Genetic Keys to Fight HPV-Related Cancers. | Cancers (Basel) | 2023 | 38067286 | PubTator, text mining | PubMed |
| Chimeric Antigen Receptor T Cell Therapy Targeting Epithelial Cell Adhesion Molecule in Gastric Cancer: Mechanisms of Tumor Resistance. | Cancers (Basel) | 2023 | 38067255 | PubTator, text mining | PubMed |
| Single-cell transcriptomics reveals variations in monocytes and Tregs between gout flare and remission. | JCI Insight | 2023 | 38063198 | PubTator, text mining | PubMed |
| Overexpression of TMEM150A in glioblastoma multiforme patients correlated with dismal prognoses and compromised immune statuses. | PLoS One | 2023 | 38055673 | PubTator, text mining | PubMed |
| Integrating scRNA-seq and bulk RNA-seq to characterize infiltrating cells in the colorectal cancer tumor microenvironment and construct molecular risk models. | Aging (Albany NY) | 2023 | 38054820 | PubTator, text mining | PubMed |
| Integration of Single-Cell Transcriptomics Data Reveal Differences in Cell Composition and Communication in Acne. | Clin Cosmet Investig Dermatol | 2023 | 38053721 | PubTator, text mining | PubMed |
| Spatial transcriptomics deconvolution at single-cell resolution using Redeconve. | Nat Commun | 2023 | 38040768 | PubTator, text mining | PubMed |
| Neoantigen-targeted TCR-engineered T cell immunotherapy: current advances and challenges. | Biomark Res | 2023 | 38037114 | PubTator, text mining | PubMed |
| Dynamic regulatory elements in single-cell multimodal data implicate key immune cell states enriched for autoimmune disease heritability. | Nat Genet | 2023 | 38036783 | PubTator, text mining | PubMed |
| Mapping and modeling human colorectal carcinoma interactions with the tumor microenvironment. | Nat Commun | 2023 | 38036590 | PubTator, text mining | PubMed |
| Unraveling immunotherapeutic targets for endometriosis: a transcriptomic and single-cell analysis. | Front Immunol | 2023 | 38035102 | PubTator, text mining | PubMed |
| Construction of EMT related prognostic signature for kidney renal clear cell carcinoma, through integrating bulk and single-cell gene expression profiles. | Front Pharmacol | 2023 | 38035023 | PubTator, text mining | PubMed |
| A novel prognostic signature and immune microenvironment characteristics associated with disulfidptosis in papillary thyroid carcinoma based on single-cell RNA sequencing. | Front Cell Dev Biol | 2023 | 38033866 | PubTator, text mining | PubMed |
| Single-cell analysis unveils activation of mast cells in colorectal cancer microenvironment. | Cell Biosci | 2023 | 38031173 | PubTator, text mining | PubMed |
| PD-1- CD45RA+ effector-memory CD8 T cells and CXCL10+ macrophages are associated with response to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma. | Nat Commun | 2023 | 38030622 | PubTator, text mining | PubMed |
| Identification of the key immune-related genes and immune cell infiltration changes in renal interstitial fibrosis. | Front Endocrinol (Lausanne) | 2023 | 38027143 | PubTator, text mining | PubMed |
| Engineering T cell receptor fusion proteins using nonviral CRISPR/Cas9 genome editing for cancer immunotherapy. | Bioeng Transl Med | 2023 | 38023726 | PubTator, text mining | PubMed |
| Integrative analysis reveals a four-gene signature for predicting survival and immunotherapy response in colon cancer patients using bulk and single-cell RNA-seq data. | Front Oncol | 2023 | 38023180 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/915/papers?page=15